Home › Steatotic Liver Disease › Arizona › Tucson

Pag-aaral pangklinika para sa Steatotic Liver Disease sa Tucson, AZ

Isang pag-aaral para sa Steatotic Liver Disease ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Tucson. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Nagre-recruitPhase 3

89bio Clinical Study Site, Tucson
89bio Clinical Study Site, Tucson
89bio Clinical Study Site, Tucson

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Nagre-recruitPhase 3

89bio Clinical Study Site, Tucson
89bio Clinical Study Site, Tucson

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06318169

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

Nagre-recruitPhase 2

Arizona Liver Health - Tucson, Tucson

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07527910

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Nagre-recruitPhase 2

Adobe Clinical Research, Tucson
Arizona Liver Health - Tucson, Tucson
Del Sol Research Management, LLC, Tucson

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Nagre-recruitPhase 3

The Institute for Liver Health II dba Arizona Clinical Trials - Tucson, Tucson
Del Sol Research Management, LLC, Tucson

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Nagre-recruitPhase 3

Akero Clinical Study Site, Tucson
Akero Clinical Study Site, Tucson
Akero Clinical Study Site, Tucson
at 1 pa

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06528314

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Nagre-recruitPhase 2

Adobe Clinical Research, LLC, Tucson
Arizona Liver Health - Tucson, Tucson

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07288138

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

Nagre-recruitPhase 2

GSK Investigational Site, Tucson
GSK Investigational Site, Tucson

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06613698

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Nagre-recruitPhase 3

GSK Investigational Site, Tucson

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT07221227

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

Nagre-recruitPhase 2

GSK Investigational Site, Tucson

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 8, 2026 · NCT06920043

Pag-aaral para sa Steatotic Liver Disease sa ibang lungsod

Iba pang pag-aaral sa Tucson

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.